Literature DB >> 11886350

Predictive factors for diagnosis of advanced-stage squamous cell carcinoma of the head and neck.

André L Carvalho1, Javier Pintos, Nicolas F Schlecht, Benedito V Oliveira, Antonio S Fava, Maria P Curado, Luiz P Kowalski, Eduardo L Franco.   

Abstract

OBJECTIVE: To identify the predictive factors (with emphasis on diagnostic delay) associated with the diagnosis of an advanced-clinical stage head and neck cancer.
DESIGN: Cross-sectional study of patients with head and neck cancer originally recruited for a case-control study.
SETTING: Three referral oncological centers in metropolitan areas in southern Brazil: São Paulo, Curitiba, and Goiânia. PATIENTS: The study population comprised 679 patients recently diagnosed as having a previously untreated head and neck squamous cell carcinoma. MAIN OUTCOME MEASURE: Diagnosis of advanced disease (clinical stage III-IV) head and neck cancer.
RESULTS: Patients with laryngeal and hypopharyngeal cancers were more likely to be diagnosed as having advanced disease than those with lip, oral, and oropharyngeal cancers (88.0% vs 74.6%) (P<.001). Patient delay was inversely associated with clinical stage at diagnosis in patients with the same cancers, while professional delay was directly associated with a higher risk of advanced clinical stage at diagnosis (P =.001 and P =.006, respectively). In the analysis of laryngeal and hypopharyngeal cancer, both patient and professional delays were associated with advanced disease, with patient delay being a stronger predictive factor than professional delay.
CONCLUSIONS: Clinical stage at diagnosis was associated with sociodemographic characteristics, patient delay, and professional delay. Our results indicate that continued educational programs for the population and health care professionals regarding the identification of early symptoms of head and neck cancers are warranted.

Entities:  

Mesh:

Year:  2002        PMID: 11886350     DOI: 10.1001/archotol.128.3.313

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  17 in total

1.  [Delayed diagnosis of oral squamous cell neoplasms at different sites].

Authors:  T Xu; D C Wang; X F Shan; Z G Cai
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

2.  Identification of Salivary Proteomic Biomarkers for Oral Cancer Screening.

Authors:  Shigeo Ishikawa; Kenichi Ishizawa; Atsushi Tanaka; Hirohito Kimura; Kenichiro Kitabatake; Ayako Sugano; Kaoru Edamatsu; Shohei Ueda; Mitsuyoshi Iino
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

3.  Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.

Authors:  Colin T Murphy; Thomas J Galloway; Elizabeth A Handorf; Brian L Egleston; Lora S Wang; Ranee Mehra; Douglas B Flieder; John A Ridge
Journal:  J Clin Oncol       Date:  2015-11-30       Impact factor: 44.544

Review 4.  Psychological factors associated with head and neck cancer treatment and survivorship: evidence and opportunities for behavioral medicine.

Authors:  M Bryant Howren; Alan J Christensen; Lucy Hynds Karnell; Gerry F Funk
Journal:  J Consult Clin Psychol       Date:  2012-09-10

5.  Autoantibody approach for serum-based detection of head and neck cancer.

Authors:  Ho-Sheng Lin; Harvinder S Talwar; Adi L Tarca; Alexei Ionan; Madhumita Chatterjee; Bin Ye; Jerzy Wojciechowski; Saroj Mohapatra; Marc D Basson; George H Yoo; Brian Peshek; Fulvio Lonardo; Chuan-Ju G Pan; Adam J Folbe; Sorin Draghici; Judith Abrams; Michael A Tainsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11       Impact factor: 4.254

6.  Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas.

Authors:  Yuxuan Wang; Simeon Springer; Carolyn L Mulvey; Natalie Silliman; Joy Schaefer; Mark Sausen; Nathan James; Eleni M Rettig; Theresa Guo; Curtis R Pickering; Justin A Bishop; Christine H Chung; Joseph A Califano; David W Eisele; Carole Fakhry; Christine G Gourin; Patrick K Ha; Hyunseok Kang; Ana Kiess; Wayne M Koch; Jeffrey N Myers; Harry Quon; Jeremy D Richmon; David Sidransky; Ralph P Tufano; William H Westra; Chetan Bettegowda; Luis A Diaz; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Nishant Agrawal
Journal:  Sci Transl Med       Date:  2015-06-24       Impact factor: 17.956

7.  Identification of salivary metabolomic biomarkers for oral cancer screening.

Authors:  Shigeo Ishikawa; Masahiro Sugimoto; Kenichiro Kitabatake; Ayako Sugano; Marina Nakamura; Miku Kaneko; Sana Ota; Kana Hiwatari; Ayame Enomoto; Tomoyoshi Soga; Masaru Tomita; Mitsuyoshi Iino
Journal:  Sci Rep       Date:  2016-08-19       Impact factor: 4.379

8.  Spatial analysis of the death associated factors due oral cancer in Brazil: an ecological study.

Authors:  Gisele Pedroso Moi; Ageo Mário Cândido Silva; Noemi Dreyer Galvão; Marcelo de Castro Meneghim; Antonio Carlos Pereira
Journal:  BMC Oral Health       Date:  2018-01-23       Impact factor: 2.757

9.  Volatilomic insight of head and neck cancer via the effects observed on saliva metabolites.

Authors:  Ravindra Taware; Khushman Taunk; Jorge A M Pereira; Amey Shirolkar; Dharmesh Soneji; José S Câmara; H A Nagarajaram; Srikanth Rapole
Journal:  Sci Rep       Date:  2018-12-07       Impact factor: 4.379

10.  The predictive factors of primary head and neck cancer stage at presentation and survival in a developing nation's tertiary hospital.

Authors:  Adeyi A Adoga; Daniel D Kokong; Nuhu D Ma'an; Joyce G Mugu; Chukwunonso J Mgbachi; Ayuba M Dauda
Journal:  SAGE Open Med       Date:  2018-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.